Calamos Advisors’s Templeton Emerging Markets Fund EMF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$934K Sell
40,216
-4,975
-11% -$108K ﹤0.01% 764
2026
Q1
$790K Buy
45,191
+5,380
+14% +$102K ﹤0.01% 826
2025
Q4
$678K Buy
39,811
+15,750
+65% +$268K ﹤0.01% 732
2025
Q3
$403K Buy
24,061
+4,295
+22% +$66.2K ﹤0.01% 788
2025
Q2
$288K Sell
19,766
-1,718
-8% -$22.7K ﹤0.01% 794
2025
Q1
$276K Sell
21,484
-859
-4% -$10.9K ﹤0.01% 773
2024
Q4
$267K Buy
22,343
+4,295
+24% +$55.4K ﹤0.01% 782
2024
Q3
$244K Sell
18,048
-6,720
-27% -$85.2K ﹤0.01% 779
2024
Q2
$306K Buy
24,768
+7,855
+46% +$94.9K ﹤0.01% 744
2024
Q1
$202K Buy
+16,913
New +$195K ﹤0.01% 773

Other funds holding EMF

Calamos Advisors's EMF Position: Q2 2026 in Review

Calamos Advisors reduced its Templeton Emerging Markets Fund (EMF) stake by 11% in Q2 2026, selling an estimated $108K and leaving 40,216 shares worth $934K. The position accounts for ﹤0.01% of the portfolio, ranked #764.

Calamos Advisors first reported a position in EMF in Q1 2024 and has held it in 10 quarters since. 15 funds tracked by Wall St. Rank hold EMF as of Q2 2026.

  • Calamos Advisors held 40,216 shares of Templeton Emerging Markets Fund worth $934K as of Q2 2026.
  • Calamos Advisors sold 4,975 Templeton Emerging Markets Fund shares in Q2 2026, an estimated $108K.
  • Templeton Emerging Markets Fund made up ﹤0.01% of Calamos Advisors's portfolio in Q2 2026, its #764 holding.
  • Calamos Advisors first reported a position in Templeton Emerging Markets Fund in Q1 2024 and has held it in 10 quarters since.
  • 15 funds tracked by Wall St. Rank held Templeton Emerging Markets Fund as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.